~~<i id='D351E0B67E'><strike id='D351E0B67E'><tt id='D351E0B67E'><pre id='D351E0B67E'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

hotspot

author：fashion 2025-09-02 09:39:52 - browse：5992

Adam's take main illustration — Molly Ferguson/STAT

I was wrong about Geron.

For years, I’ve believed — and declared publicly — that Geron’s effort to develop a blood cancer drug called imetelstat would end in disappointment. The drug was never getting approved, I said.

On Thursday, a group of outside experts convened by the Food and Drug Administration voted 12-2 in imetelstat’s favor, concluding the drug’s benefits outweighed its risks for the treatment of patients with myelodysplastic syndrome. The strong endorsement makes an FDA approval highly likely. The decision is expected on or before June 16.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Readout Newsletter: Novavax stock, FogPharma, Novo Nordisk

Wikipedia

focus

explore

leisure time

hotspot

knowledge

SeanGallup/GettyImagesGutChecklooksathealthclaimsmadebystudies,newsmakers,orconventionalwisdom.Weask

WSS

Getting Alzheimer's drug Leqembi to patients can be a challenge

Juul documents reveal insider tactics on political lobbying

After traumatic brain injury, life support decisions can use more time

Websites selling Wegovy, Zepbound ingredients targeted by FDA

Juul documents reveal insider tactics on political lobbying

MassMutual is introducing free genetic testing for members

entertainment

hotspot

Wikipedia

As demand for Covid shots wanes, Moderna seeks its next success

Why does health care cost so much? A reading guide

Tori Bowie and the unacceptable rates of Black maternal death

BIO: Crackdown on China pharma industry would threaten U.S. drug supply

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Key Senate committee drafts bipartisan bill to stem drug shortages

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

AMAs digital advisors table RPM coding reform proposal, again

Heart attack and stroke risk calculators need revising

ACIP vaccine advisory panel sees its vacancies filled

focus

Why don't Americans have at

Doctors on social media are being harassed and cyberbullied

More tobacco lobbyists active in statehouses

Abbott's new heart device gets FDA advisory panel nod

Here’s what’s in the FDA plan to include pregnant women in clinical trials

MultiPlan and major insurers sued for alleged medical price

explore

leisure time

hotspot

knowledge